Bottom line
Is IQLT a good fund? The bottom line
IQLT is an index international stock ETF from iShares.
Annual fees run 0.3% — about $30 a year on every $10,000 invested, cheaper than 90% of international stock funds we track.
It returned +1.7% over one year, +5.5% a year over five years, +6.4% a year over ten (as of Dec 31, 2024, per its prospectus).
With $13.8 billion in net assets and 320 holdings, its largest position is ASML Holding N.V. (5.4%) and the top 10 make up 22.6% of the portfolio.
The closest lower-cost alternative we found is FSPSX (0.035%, 57% top-holdings overlap).
What stands out
- Low cost: cheaper than 90% of international stock peers
- Broadly diversified (320 holdings)
- Large and established ($13.8 billion)
Updated Nov 19, 2026
What IQLT invests in
The iShares MSCI Intl Quality Factor ETF (the Fund ) seeks to track the investment results of an index that measures the performance of international developed large- and mid-capitalization stocks exhibiting relatively higher quality characteristics as identified through three fundamental variables: return on equity, earnings variability and debt-to-equity.
The Fund seeks to track the investment results of the MSCI World ex USA Sector Neutral Quality Index (the Underlying Index ), which is based on a traditional market capitalization-weighted parent index, the MSCI World ex USA Index (the Parent Index ). The Parent Index includes equity securities in approximately the top 85% of equity market capitalization in developed market countries, as defined by MSCI Inc. (the Index Provider or MSCI ), excluding the U.S. The Underlying Index seeks to measure the performance of securities in the Parent Index that exhibit higher quality characteristics relative to their peers within the corresponding Global Industry Classification Standard (GICS ) sector. To construct the Underlying Index, the Index Provider determines the quality score of each security in the Parent Index based on three fundamental variables: high return on equity, stable…
From the fund's prospectus (filed Nov 21, 2025).
IQLT performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| IQLT | +1.7% | +5.5% | +6.4% |
| International Stock median | +25.5% | +6.4% | +7.6% |
Source: Fund prospectus, as of Dec 31, 2024
What IQLT costs
On a $10,000 investment, IQLT's 0.3% expense ratio costs about $30 a year. The prospectus estimates $381 in total costs over 10 years (assuming 5% annual returns). The median international stock fund charges 0.9%.
IQLT top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | ASML Holding N.V. | 5.42% |
| 2 | Allianz SE | 2.68% |
| 3 | Roche Holding AG | 2.20% |
| 4 | ABB Ltd | 1.95% |
| 5 | Zurich Insurance Group AG | 1.83% |
| 6 | Nestle S.A. | 1.81% |
| 7 | Novartis AG | 1.78% |
| 8 | Astrazeneca Plc | 1.68% |
| 9 | Advantest Corporation | 1.65% |
| 10 | Shell Plc | 1.59% |
Source: SEC Form N-PORT, period ended Jul 31, 2026
The top 10 make up 22.6% of the fund. See all top 25 holdings and asset mix →
Alternatives to IQLT
| Family | Fund | Expense ratio | Overlap | |
|---|---|---|---|---|
| Fidelity | FSPSX Fidelity International Index Fund | 0.035% | 57% | Compare |
| Schwab | SWISX Schwab International Index Fund | 0.06% | 52% | Compare |
| J.P. Morgan | BBIN JPMorgan BetaBuilders International… | 0.07% | 57% | Compare |
| T. Rowe Price | PIEQX T. Rowe Price International Equity… | 0.25% | 52% | Compare |
| SPDR (State Street) | QEFA State Street(R) SPDR(R) MSCI EAFE… | 0.3% | 68% | Compare |